The use of data mining techniques in biotechnology and pharmaceutical research is becoming standard practice.  These techniques are already used in basic drug and genomic research for identifying patterns in protein sequences, in bioinformatics to examine drug targets, and as a tool for identifying promising therapeutics in pharmacogenomics.  After briefly reviewing some data mining methodologies and how they differ from the standard drug assessment required by the FDA, I will present several biomedical examples which required a data mining approach for solution. Finally, I'll discuss how data mining is being used to inform health policy from a large on-going NIH trial.

“Better Health through

Data Mining”

 

featuring

 

Professor I. Elaine Allen,

Associate Professor of Math and Statistics,

Babson College

 

Wednesday, April 30th, 2003

4 to 5 PM (refreshments at 3:30 PM)

Olin Center Auditorium, Olin College